Digital pharmacy startup Hims & Hers Health is introducing access to compounded GLP-1 weight loss injections, the company announced Monday. The company, which offers a range of direct-to-consumer treatments for conditions like erectile dysfunction and hair loss, launched a weight loss program in December. But GLP-1 medications — the class of drugs like Ozempic and Wegovy that have skyrocketed in popularity — were not previously offered as part of that program. Customers can access the compounded GLP-1 medications via a prescription from a licensed healthcare providers on the Hims & Hers platform. The company's oral medication kits start at $79 a month, and its compounded GLP-1 injections will start at $199 a month.

---

Persons: Andrew Dudum, Dudum Organizations: Novo Nordisk, FDA, U.S . Food, Drug Administration, CNBC, & $ Locations: U.S